UK markets close in 6 hours 36 minutes

  • FTSE 100

    6,617.62
    -33.26 (-0.50%)
     

  • FTSE 250

    21,136.83
    -159.40 (-0.75%)
     

  • AIM

    1,163.75
    -9.64 (-0.82%)
     

  • GBP/EUR

    1.1585
    -0.0012 (-0.10%)
     

  • GBP/USD

    1.3818
    -0.0076 (-0.55%)
     

  • BTC-GBP

    34,145.50
    -2,445.15 (-6.68%)
     

  • CMC Crypto 200

    943.37
    -43.84 (-4.44%)
     

  • S&P 500

    3,768.47
    -51.25 (-1.34%)
     

  • DOW

    30,924.14
    -345.95 (-1.11%)
     

  • CRUDE OIL

    65.21
    +1.38 (+2.16%)
     

  • GOLD FUTURES

    1,689.60
    -11.10 (-0.65%)
     

  • NIKKEI 225

    28,864.32
    -65.79 (-0.23%)
     

  • HANG SENG

    29,098.29
    -138.50 (-0.47%)
     

  • DAX

    13,927.71
    -128.63 (-0.92%)
     

  • CAC 40

    5,780.36
    -50.29 (-0.86%)
     
Ranking:

London retains title of most popular city for work

Despite Brexit and the pandemic, London has held the title for the last eight years

Shares in Reddit favourites GameStop and AMC fall in Frankfurt

Oscar Williams-Grut
·Senior City Correspondent, Yahoo Finance UK
·1-min read
A GameStop store in Athens, Ohio, US. Photo: Stephen Zenner/SOPA Images/LightRocket via Getty
A GameStop store in Athens, Ohio, US. Photo: Stephen Zenner/SOPA Images/LightRocket via Getty

German-listed shares in hot ‘memestocks’ GameStop and AMC fell sharply in early trade in Frankfurt on Thursday, suggesting volatility is not over for the two stocks.

GameStop (GS2C.F) shares fell 12.5% in early trade in Frankfurt, while AMC (AH9.F) lost 9.8%.

The two companies, both of which have their main listings in the US, have been the subject of frenzied interest from retail investors over the last two weeks. Investors on Reddit’s r/WallStreetBets forum targeted both companies for investment given the high short interest from hedge funds.

WATCH: GameStop was a solid buy even before Reddit-fueled jump: veteran trader

The stock price of both GameStop (GME) and AMC (AMC) surged last week as retail investors sought to ‘squeeze’ hedge funds out of their short trades, leading to billions of dollars in losses for some hedge funds. GameStop and AMC then fell rapidly back to earth this week.

So-called ‘memestocks’ “seemed to calm down” on Wednesday, said Deutsche Bank strategist Jim Reid. Wednesday marked the first session in over a week that GameStop didn’t see a double digit percentage move either higher or lower on the day.

Thursday’s early price action in Frankfurt suggests the two shares could be hit by more volatility when trading begins later today in New York.

WATCH: GameStop mania: 'SEC doesn’t protect investors from themselves'

Latest stories

  • Sean Dyche does not expect a radical shift in transfer policy under new owners

    Dyche has operated under something of a financial straitjacket for many years at Turf Moor.

  • Volkswagen core brand to accelerate electric vehicle shift

    Volkswagen's namesake brand plans to more than double the share fully electric vehicles have in total European sales by 2030, the company said on Friday, in a bid to accelerate the carmaker's shift towards battery-powered cars. Fully electric vehicles are expected to account for more than 70% of total European vehicle sales by 2030, compared with a previous target of 35%, the world's second-largest carmaker said as it unveiled its 'Accelerate' strategy. "With Accelerate we are increasing the speed on our path to a digital future," said Ralf Brandstaetter, who heads the Volkswagen brand and also sits on the group's management board.

  • Dannii Minogue on accepting herself: 'There was nothing wrong with me - I was just petite'

    The Australian singer has created a new petite clothing range after years of struggling to find clothes that fit her.

  • The Hawaiian Shirt Returns to the Island

    Forget painterly prints and experimental graphics, this spring the Hawaiian shirt is all about the Aloha

  • Global Wet Macular Degeneration Epidemiology and Market Forecast to 2030: Current Treatment Practices and Unmet Needs - ResearchAndMarkets.com

    The "Wet Macular Degeneration - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

  • Sterling weakens against resurgent dollar

    The British pound lost ground against a resurgent dollar on Friday, as currency traders took some risk off the table amid rising U.S. bond yields. U.S. Federal Reserve Chair Jerome Powell failed to soothe investor concerns about a recent surge in borrowing costs as he spoke at a Wall Street Journal forum on Thursday, pushing the safe-haven dollar higher. The pound had reached as high as $1.42 last month - its highest level since 2018 - as optimism built about Britain's swift introduction of COVID-19 vaccines and expectations of a robust economic recovery.

  • Abhorrent attack on pensioner with leukaemia leaves her badly bruised

    Ida Brown, 79, was confronted by two men at the back door of her home in Gateshead as they tried to steal her mobility scooter.

  • Global Stents Market Report 2021-2027 - Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries

    Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Stents Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The global stents market is expected to reach $13,522.8 million by 2027, growing at a mid single digit CAGR from 2020 to 2027. The market is segmented by product, material, application, end-users and geography. Stents are the miniaturized, flexible or expandable tube like structures used to widen and establish patency of the clogged vascular or non-vascular tubular structures and to ensure steady flow of body fluids through them. Compared to the traditional highly invasive surgical repair procedures, the current minimally invasive transcatheter therapeutic procedures with highly efficient, technologically advanced stent products assure patients and healthcare providers with improved efficiency, effectiveness and quicker restoration of the narrowed vessel's or duct's natural function. Increased utilization of the various stent products for the numerous and varied types of vascular and non-vascular obstructive conditions and cerebral aneurysm among the patients, elevating inclination of the value centric global patient pool towards the minimally invasive, technologically advanced stent products with better therapeutic outcomes and the need to rapidly mitigate the clinical manifestations associated with blocked vascular and non-vascular hollow organs or weakened vascular bed, reduce hospitalization duration and ease and improve the patient's condition quickly through efficient and safer interventional products are fuelling the stents global market. The stents global market is consolidated with few companies dominating and occupying major share of the market. Some of the leading players in stents market are Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Cook Medical LLC (U.S.), Cardinal Health Inc. (U.S.), Becton, Dickinson and company (U.S.), B. Braun Melsungen AG (Germany), Biotronik SE & Co. KG (Germany), Blue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.) (China) and others. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis3.1 Introduction3.2 Market Segmentation3.3 Factors Influencing Market3.3.1 Drivers and Opportunities3.3.1.1 Escalating Prevalence of Vascular and Non-Vascular Stenotic Diseases and Cerebral Aneurysm3.3.1.2 Elevating Inclination Towards Minimally Invasive Therapeutic Approaches3.3.1.3 The Trend of Coronary Stent Price Slashing and Increasing Competitiveness of Domestic Players in APAC Countries3.3.1.4 Emergence of Technologically Advanced Products3.3.1.5 Escalating Geriatric Population and Feasibility of Drug Eluting Stents in Them3.3.1.6 Acquisitions and Distribution Agreements to Open an Array of Opportunities for the Market to Flourish3.3.1.7 Favourable Reimbursement Policies Escalating Stent Technology Diffusion in Developed Nations3.3.2 Restraints and Threats3.3.2.1 Stringent Regulatory Bodies Guiding Stent Manufacturers3.3.2.2 The Threat of Commercialized Stent Recalls3.3.2.3 Lack of Skilled, Experienced and Trained Healthcare Professionals3.3.2.4 Adverse Effects of Stents3.3.2.5 Concerns Over Irrational Stenting and Under-Performance of Stents in Complex Stenotic Diseases or Lesions3.4 Regulatory Affairs3.4.1 International Organization for Standardization3.4.1.1 ISO 9001: 2015 Quality Management System3.4.1.2 ISO 14644-1 Clean Room Standards3.4.1.3 ISO 13485 Medical Devices3.4.1.4 ISO 10993 Biological Evaluation of Medical Devices3.4.1.5 ISO 14971: Risk Management of Medical Devices3.4.1.6 ISO 25539-2: 2020 Cardiovascular Implants - Endovascular Devices - Part 2: Vascular Stents3.4.1.7 ISO 25539-13.4.1.8 ISO 12417-13.4.1.9 ISO/TS 171373.4.1.10 ISO 17327-13.4.1.11 IEC 60601-1 Medical Electrical Equipment Standard3.4.2 ASTM International Standards3.4.3 U.S.3.4.4 Canada3.4.5 Europe3.4.6 Japan3.4.7 China3.4.8 India3.5 Technological Advancements3.5.1 Introduction3.5.2 Smart Stents3.5.3 3D-Printed Stents3.5.4 Indirect 4D Printing and Microstents3.5.5 Nanocoated Non-Drug Eluting Stent and Ultrashort DAPT3.5.6 Bioengineered Stents3.5.7 Gene Eluting Stents (GES)3.5.8 Bioresorbable Stents3.6 Stents Coating Materials3.6.1 Inorganic Coating Materials3.6.2 Organic Coating Materials3.6.3 Biological Coating Materials or Biocoatings3.6.4 Chemotheraputics or Drugs3.7 Porter's Five Force Analysis3.8 Supply Chain Analysis3.9 Reimbursement Scenario3.10 Patent Trends3.11 Regulatory Approval Analysis3.12 Clinical Trials3.13 Market Share Analysis by Major Players3.13.1 Stents Global Market Share Analysis3.13.2 Coronary Stents Global Market Share Analysis3.13.3 Peripheral Stents Global Market Share Analysis3.13.4 Neurovascular Stents Global Market Share Analysis3.13.4.1 Flow Diverters Global Market Share Analysis3.13.4.2 Intracranial Stent Global Market Share Analysis3.13.4.3 Carotid Stent Global Market Share Analysis3.13.5 Gastrointestinal Stents Global Market Share Analysis3.13.6 Drug Eluting Stents Global Market Share Analysis3.14 Stents - Number of Procedures by Region3.15 Stents Company Comparison Table by Revenue, Product, Product Type, Application, Material and Indication 4 Stents Global Market, by Product4.1 Introduction4.2 Bare Metal Stents4.3 Drug Eluting Stents4.4 Bioresorbable Stents4.5 Other Stents 5 Stents Global Market, by Material5.1 Introduction5.2 Metal Alloy Based Stents5.3 Polymer Based Stents 6 Stents Global Market, by Application6.1 Introduction6.2 Vascular Stents6.3 Non-Vascular Stents 7 Stents Global Market, by End-users7.1 Introduction7.2 Hospitals7.3 Ambulatory Surgery Centers7.4 Other End-users 8 Regional Analysis 9 Competitive Landscape9.1 Introduction9.2 Product Approval9.3 Clinical Studies/Investigations9.4 Product Launch9.5 Acquisition9.6 Other Developments 10 Major Companies Abbott LaboratoriesBraun Melsungen AGBecton, Dickinson and CompanyBiotronik SE & Co. KGBlue Sail Medical Co. Ltd. (Biosensors International Pte. Ltd.)Boston Scientific CorporationCardinal Health Inc.Cook Medical LLCMedtronic plcTerumo Corporation Companies Mentioned Abbott LaboratoriesAbbvie Inc.Acandis GmbHAccura Medizintechnik GmbHAllium Ltd.AlvimedicaAndraTec GmbHArterius LimitedB. Braun Melsungen AGB.Braun Melsungen AGBalt ExtrusionBalton Sp. z o.o.Becton, Dickinson and CompanyBentley InnoMed GmbHBess AGBioteque CorporationBiotronik SE & Co. KGBlue Sail Medical Co. Ltd.Boston Scientific CorporationCardinal Health Inc.CeloNova BioSciences, Inc.Conmed CorporationCook Medical LLCDisa VascularDispomedica GmbHElixir Medical CorporationELLA - CS, s.r.oEndocor GmbHEndoGI MedicalEucatech AGEuroCor Tech GmbHGENOSS Co. Ltd.Glaukos CorporationHexacath InternationalHydrUStent SAInspireMDIvantis Inc.iVascular S.L.U.Kyoto Medical Planning Co. Ltd.Lepu Medical TechnologyM.I.TECH Co. Ltd.Med pro Medical B.V.Medas Inc.Medicut Stent Technology GmbHMedinol Ltd.Medtronic plcMeril Life Sciences Pvt. Ltd.Merit Medical Systems Inc.Merlin MD Pte. Ltd.Micell Technologies, Inc.Micro Science Medical AGMicro-TechMicroport Scientific CorporationNanostentNumed Inc.Olympus CorporationOptimed Medizinische Instrumente GmbHOpto CircuitsOrbusNeich Medical Company LimitedPalex Medical SAPhenox GmbHPlus medica Nordic ABPNN Medical A/SPoseidon Medical Inc.Q3 Medical Devices Ltd.Relisys Medical Devices LimitedREVA Medical Inc.Rontis AGSahajanand Medical Technologies Pvt. Ltd.Scitech Produtos Medicos SASilk Road Medical Inc.Stening SrlSvelte Medical Systems Inc.Synlas GmbH & Co. KGTaewoong Medical Co. Ltd.Terumo CorporationThoracent, Inc.Translumina TherapeuticsUSM Healthcare Medical Devices Factory JSCVygon SAW. L. Gore & Associates, Inc.Wellinq Holding B.V.Zhejiang Chuangxiang Medical Technology Co. Ltd. For more information about this report visit https://www.researchandmarkets.com/r/68lqk3 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Government defends recommendation of 1% pay rise for NHS workers

    Unions express more anger after minister says Government cannot afford more than 1%

  • Tory minister ‘pleasantly surprised’ by 1% pay rise for NHS staff

    Nadine Dorries says nurses ‘do their job because they love their job’ amid outrage over ‘pitiful’ increase

  • South African Manufacture of Flour and Grain Mill Products 2021, Featuring Profiles of 18 Key Players - ResearchAndMarkets.com

    The "Manufacture of Flour and Grain Mill Products in South Africa 2021" report has been added to ResearchAndMarkets.com's offering.

  • Keely Hodgkinson and Andrew Pozzi aim for glory at European Indoor Championships

    Team GB will be hopeful of success in Torun in the build-up to the Olympics later this year

  • U.S., U.K. Weigh Russia Sanctions, Possibly Targeting Debt

    (Bloomberg) -- The U.S. and U.K. are weighing additional penalties against Russia over the use of chemical weapons, with options ranging from sanctions against oligarchs to the extreme step of targeting the nation’s sovereign debt, according to people familiar with the matter.British officials plan to push for the Organisation for the Prohibition of Chemical Weapons to continue to pressure Russia to provide answers over its use of banned substances, and will raise potential measures with key European allies, including France and Germany, in the coming weeks, according to one of the people.The Biden administration announced its first sanctions against Russia on Tuesday, punishing the Kremlin for the poisoning and jailing of opposition leader Alexey Navalny. The penalties mirrored those imposed by the European Union and the U.K., mainly targeting senior Russian law enforcement officials and others allied with President Vladimir Putin.Russian bonds snapped a four-day rally, lifting the yield 11 basis points to 6.68% as of 12:21 p.m. in Moscow. Buoyed by climbing oil prices, the ruble was 0.3% stronger at 74.46 per dollar after slipping 1% on Thursday.The U.S. is expected to closely adhere to a 1991 chemical weapons law and follow-up with a second, more extensive round of sanctions unless Russia meets certain conditions, according to people familiar with the matter. Those include assurances it will refrain from the use of such weapons and allow inspections of suspected chemical weapons sites.The penalties were the latest sign of deepening tensions between Washington and Moscow, and the relationship could deteriorate further if Russia retaliates or the U.S. escalates its sanctions.All of the people spoke on condition of anonymity owing to the sensitivity of the matter. Communications aides at the White House National Security Council and the U.K. Foreign Office had no immediate comment Thursday.British officials are in discussions with U.S. counterparts about new measures. One trigger for additional steps would be if Russia continues to stonewall an investigation into Navalny’s poisoning, one person said.U.K. Foreign Secretary Dominic Raab on Thursday urged Russia to adhere to its obligations under international law.“These attacks are unacceptable. We urge Russia to investigate, adhere to its obligations under the Chemical Weapons Convention,” Raab tweeted.U.S. Secretary of State Antony Blinken sent a similar message Thursday.The U.S. could increase pressure on Russia with sanctions on oligarchs with powers under the Magnitsky Act, which authorizes the president to sanction individuals for human rights violations or corruption, the people said.But if Russia is again found to commit a major transgression of the international ban on chemical weapons, President Joe Biden would consider imposing sanctions on the nation’s sovereign debt if it could be done in cooperation with Europe, two of the people said.The Treasury Department under former Secretary Steven Mnuchin in 2018 warned of global financial market turmoil if Russia’s sovereign debt market were sanctioned, saying it could destabilize markets because of how deeply tied the Russian market is to global indexes.But others say that Russia has moved away from buying U.S.-denominated debt toward the euro, meaning that negative spillovers could be smaller than previously anticipated. That view is shared by Daleep Singh, a former Obama-era Treasury official, who is now a deputy on Biden’s National Security Council.In 2019, as a witness during a congressional hearing on Russia, Singh supported restricting purchases of Russian sovereign debt to protect U.S. national security interests. At the time, he said that damage to global markets resulting from prohibiting purchases of Russian debt would not be as significant because global investors have reduced their overall exposure to the nation since the Obama administration started sanctioning Russia in 2014.(Updates with bonds falling in fourth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Can Manchester City ever be bigger than Manchester United?

    Pep Guardiola has created an identity at the Etihad, a key pillar in deciding the true size of a club

  • Can Manchester United evolve under Ole Gunnar Solskjaer in the way City have under Pep Guardiola?

    City are a different team from the one which played out a goalless draw at Old Trafford in December

  • M&S reveals its Easter Yumnuts... Hot Cross Yumnuts!

    So that's a Yum Yum + donut hybrid, crossed with a hot cross bun? A trybrid?

  • Designing Stark Compliant Physician Compensation Models - Virtual Webinar Session - ResearchAndMarkets.com

    The "6-Hour Virtual Seminar on Designing Stark Compliant Physician Compensation Models" webinar has been added to ResearchAndMarkets.com's offering.

  • Israeli miniser says has list of Iran-backed targets

    Israel’s defense minister says his country has drawn up plans to strike Iranian targets if Tehran shows signs of nuclear escalation. Benny Gantz told Fox News that Israel is still working on its plans, but “we have them in our hands of course.” The remarks come as President Joe Biden’s administration considers re-joining the 2015 Iran nuclear deal to limit Iran's nuclear program, with some changes to toughen curbs on Tehran's activities.

  • Global Probiotic Cosmetic Products Market Report 2021: Market Size is Expected to Reach $400 Million by 2026, Rising at a CAGR of 11%

    Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Probiotic Cosmetic Products Market By Distribution Channel (Hypermarket & Supermarket, Pharmacy & Drug Store, E-commerce and other Distribution Channels), By Product (Skin care and Hair Care), By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Probiotic Cosmetic Products Market size is expected to reach $400 Million by 2026, rising at a market growth of 11% CAGR during the forecast period. Probiotic skincare cosmetic products are considered as beauty products that help in increasing the healing benefits of good microorganisms present in our skin. Such products are also in high demand as they control the natural immune response of the skin and create better skin immunity and resilience. The market of probiotic skincare cosmetic products is witnessing a rising growth graph as these products are really beneficial in maintaining bright skin and aid in preventing issues related to skin.For attaining a competitive advantage over others, the people in this market are always in the pursuit of developing products that are profitable and have a positive impact on consumers. Manufacturers also strive to produce cosmetic products mixed with probiotics and other products to improve the quality of cosmetic products.The increasing adoption of probiotics as dietary supplement, probiotics witness a massive demand in the cosmetics category, hence boosting the growth of the market. These cosmetic products are beneficial and suitable to all skin types and can assist in reducing problems related to eczema, chronic inflammation, rosacea, and acne.The industry has been severely impacted by the global COVID-19 pandemic. Various governments have implemented different measures to contain the spread of virus such as Stay-home policy, lockdown measures, and store closures which caused a severe decline in sales. During the pandemic, one of the major observations is that the sentiment of consumers has shifted more toward basic skincare routines and necessities, thus reducing the demand for the probiotic products. Also, the present situation has encouraged customers to step back and choose mass skincare products, which are significantly cheaper and extensively available across all distribution channels.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Estee Lauder Companies, Inc., L'Oreal Group, Unilever PLC, The Clorox Company, Health and Happiness (H&H) International Holdings Limited (Aurelia Probiotic Skincare), Esse Skincare, Tula Life, Inc., Eminence Organic Skin Care, Glowbiotics, Inc., and LaFlore Probiotic Skincare. Key Topics Covered: Chapter 1. Market Scope & Methodology1.1 Market Definition1.2 Objectives1.3 Market Scope1.4 Segmentation1.4.1 Global Probiotic Cosmetic Products Market, by Distribution Channel1.4.2 Global Probiotic Cosmetic Products Market, by Product1.4.3 Global Probiotic Cosmetic Products Market, by Geography1.5 Methodology for the researchChapter 2. Market Overview2.1 Introduction2.1.1 Overview2.1.2 Market composition and scenario2.2 Key Factors Impacting the Market2.2.1 Market Drivers2.2.2 Market RestraintsChapter 3. Global Probiotic Cosmetic Products Market by Distribution Channel3.1 Global Hypermarket & Supermarket Market by Region3.2 Global Pharmacy & Drug Store Market by Region3.3 Global E-commerce Market by Region3.4 Global Other Distribution Channels Market by RegionChapter 4. Global Probiotic Cosmetic Products Market by Product4.1 Global Skin care Market by Region4.2 Global Hair care Market by RegionChapter 5. Global Probiotic Cosmetic Products Market by RegionChapter 6. Company Profiles6.1 Company Overview6.2 Financial Analysis6.3 Regional Analysis6.4 Research & Development Expense6.5 Recent strategies and developments:6.5.1 Partnerships, Collaborations, and Agreements6.5.2 Product Launches and Product Expansions Estee Lauder Companies, Inc.L'Oreal GroupUnilever PLCThe Clorox CompanyHealth and Happiness (H&H) International Holdings Limited (Aurelia Probiotic Skincare)Esse SkincareTula Life, Inc.Eminence Organic Skin CareGlowbiotics, Inc.LaFlore Probiotic Skincare For more information about this report visit https://www.researchandmarkets.com/r/wr9vgx CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • LSE Slides as Refinitiv Costs Overshadow Confident Outlook

    (Bloomberg) -- London Stock Exchange Group Plc said it will spend more on its integration with Refinitiv this year, disappointing analysts and sending its shares falling. Capital expenditure is expected to be about 850 million pounds ($1.2 billion) in 2021, with 150 million pounds of associated operating costs, according to a statement Friday.That overshadowed the company’s confident outlook as it increased its full-year dividend by 7% for 2020. Shares dropped as much as 6.4% in London.Revenue rose to 2.1 billion pounds ($2.9 billion) in 2020 and the company proposed a final dividend of 51.7 pence a share. The group said its recently completed acquisition of Refinitiv left it well-positioned to navigate the challenges of the pandemic and Brexit.“LSEG is now truly global with a significant presence in North America, Europe, Asia and emerging markets,” Chief Executive Officer David Schwimmer said in the statement. The group “is well positioned for long-term sustainable growth.”The stock exchange completed its $27 billion purchase of Refinitiv earlier this year, kicking off a new era where the majority of its revenues come from data. Schwimmer said in a call with journalists that he expects the combination to result in some job cuts and a reduction in some of its real estate footprint.The combined company will generate about 70% of revenues from data, up from 40%, according to Bloomberg Intelligence. The parent company of Bloomberg News competes with Refinitiv to provide financial news, data and information.Schwimmer said LSEG was well-positioned to handle continuing uncertainties around how Brexit might impact the City of London.LSEG’s clearing unit remains a critical element of the European Union’s financial infrastructure even after the U.K. left the bloc. EU politicians have been vocal in demanding that companies shift euro clearing out of London and into the 27-nation bloc. They have achieved some success, with Eurex in Frankfurt increasing its share of euro clearing.Clearing VolumesSo far, though, Schwimmer said the company has seen “no discernible change” in its LCH clearing business, which can continue to service clients in the European Union through June 2022 under the bloc’s temporary rules.“Volumes continue to be very strong and if anything growing,” Schwimmer said in an interview with Bloomberg Television Friday.While London lost its crown to Amsterdam this year as the top place in Europe to buy and sell stock, the shift has had little impact on the group itself, with trades previously done on the company’s U.K. venues largely moving over to its Dutch platform.Schwimmer also welcomed proposals from a review of London’s listings rules, saying recommendations unveiled this week including on special purpose acquisition companies, or SPACs, should be adopted quickly to help London maintain its prime position.“No question, London remains one of world’s leading financial capitals,” Schwimmer said.(Updates with details throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.